Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Outpatient Sotalol Initiation
NCT05418036Phase 4Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Oct 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sotalol in Supraventricular arrhythmia (SVA) and ventricular arrhythmia (VA), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Concerns about corrected QT prolongation at 72 hours. Status: unknown.
02
Drugs
sotalol
03
Conditions
Supraventricular arrhythmia (SVA)ventricular arrhythmia (VA)
Beyond the preview
Go deeper on NCT05418036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05418036.